Sign up to save your podcasts
Or
Share HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Dr Laura Huppert from the University of California, San Francisco, discusses approved and investigational antibody-drug conjugates in the current and future management of HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6262 ratings
Dr Laura Huppert from the University of California, San Francisco, discusses approved and investigational antibody-drug conjugates in the current and future management of HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
321 Listeners
JAMA Clinical Reviews
495 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
76 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
115 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
The ONS Podcast
197 Listeners
The Clinical Problem Solvers
513 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Two Onc Docs
189 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners